HLA-C and type 1 diabetes mellitus: Inspiration comes from recent advances in the structure-guided development of reagents that block peptide binding to class II MHC molecules that predispose to T1D, including H2-Ag7 in mice (7) and HLA-DQ8 in humans (7).